[NDRA] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
14-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 36.52%
YoY- 7.24%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 6 7 287 58 0 516 -
PBT -1,847 -2,825 -2,295 -909 -1,432 -742 -687 93.69%
Tax -0 0 0 6 0 381 370 -
NP -1,847 -2,825 -2,295 -909 -1,432 -742 -687 93.69%
Tax Rate - - - - - - - -
Total Cost 1,847 2,831 2,301 1,196 1,490 742 1,202 33.26%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 -45,761.31 -33,498.39 -316.69 -2,478.35 0.00 -133.22 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -9.42 -14.40 -11.75 -4.65 -11.75 -3.80 -3.52 93.10%
EPS Diluted -9.42 -14.40 -11.75 -4.65 -11.75 -3.80 -3.52 93.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.